PMID: 16613555Apr 15, 2006Paper

Excitability of dopamine neurons: modulation and physiological consequences

CNS & Neurological Disorders Drug Targets
M MarinelliF J White

Abstract

This aim of this chapter is to review literature on the excitability and function of dopamine neurons that originate in the midbrain and project to cortico-limbic and motor structures (A9 and A10 dopamine pathways). Electrophysiological studies on rodent or non-human primates have shown that these dopamine neurons are silent or spontaneously active. The spontaneously active neurons show slow regular firing, slow irregular firing or fast bursting activity. In the first section, we will review how neuronal firing is modulated by intrinsic factors, such as impulse-regulating somatodendritic dopamine autoreceptors, a balance between inward voltage-gated sodium and calcium currents and outward potassium currents. We will then review the major excitatory and inhibitory pathways that play important roles in modulating dopamine cell excitability. In the second section, we will discuss how, in addition to being modulated by intrinsic and synaptic factors, excitability of dopamine neurons can also be modulated by life experiences. Dopamine neurons change their firing rate throughout the developmental period, their activity can be modified by stressful life events, and the firing mode can change as a consequence of acute or repeated expos...Continue Reading

Citations

Jul 16, 2011·Development and Psychopathology·Robert-Paul JusterSonia J Lupien
Nov 5, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Salvatore LeccaMarco Pistis
Oct 28, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giovanni AddoloratoAntonello Bonci
Dec 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Salvatore LeccaMarco Pistis
Feb 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stanislav KoulchitskyVincent Seutin
Jul 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Florent G RevelMarius C Hoener
Jan 11, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Arthur C RiegelEdward D French
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Marion JalabertFrançois Georges
Jul 19, 2008·Schizophrenia Bulletin·Vijay A MittalTyrone D Cannon
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Miriam Melis, Marco Pistis
Jan 16, 2008·Genes, Brain, and Behavior·M Pravetoni, K Wickman
Aug 4, 2012·The Journal of Pharmacology and Experimental Therapeutics·Stephanie M Perez, Daniel J Lodge
Mar 29, 2008·Annual Review of Clinical Psychology·Elaine WalkerKevin Tessner
Jun 23, 2012·Journal of Neurophysiology·James E McCutcheonMichela Marinelli
Mar 15, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Wai Chong WongMichela Marinelli
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michel BarrotThomas C Jhou
Aug 24, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah Y BranchMichael J Beckstead
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Darko TuricEdmund Sonuga-Barke
Nov 14, 2013·Journal of Molecular Neuroscience : MN·Chen LiHong Jiang
Mar 29, 2011·Annual Review of Neuroscience·Mariella De Biasi, John A Dani
May 13, 2010·Expert Opinion on Pharmacotherapy·Durga Prasad BesthaVishal Madaan
Sep 9, 2006·The Journal of Physiology·Elyssa B MargolisHoward L Fields
Jan 27, 2016·Molecular Neurobiology·Limin ShiJunxia Xie
Jan 10, 2013·Neuroscience·C W HoltzmanE F Walker
Jul 31, 2010·Physiology & Behavior·Marilyn ArceMark E Wilson
Apr 1, 2010·Experimental Neurology·Liana FattoreWalter Fratta
Nov 11, 2009·Hormones and Behavior·Cynthia KuhnQ David Walker
Jul 21, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marion JalabertFrançois Georges
Mar 29, 2008·Molecular and Cellular Endocrinology·L FattoreW Fratta
Jun 27, 2015·Neuropharmacology·Claudia SaghedduMarco Pistis
Jan 27, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·David Shprecher, Roger Kurlan
Jan 25, 2008·The European Journal of Neuroscience·Alice H LuoGary S Aston-Jones
Aug 24, 2007·The European Journal of Neuroscience·Joyce Colussi-MasAnne Bérod
Feb 24, 2009·The Journal of Comparative Neurology·Jennifer KauflingMichel Barrot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.